PVZB-1194 is a biphenyl-type inhibitor of the kinesin spindle protein Eg5 (KIF11), exhibiting anticancer potential by inhibiting Eg5 ATPase activity, leading to cell cycle arrest and apoptosis; it acts as an ATP-competitive inhibitor by binding to the α4/α6 allosteric pocket.